Advanced
  Home Compare Reports

Comparison with Similar Reports

IoT Medical Devices Market by Product (Blood Pressure Monitor, Glucometer, Cardiac Monitor, Pulse Oximeter, Infusion Pump), Type (Wearable, Implantabl...

Publisher:        MarketsandMarkets

# of Pages:        301

Rating: 

1 User License $4,950

Publication Date:  July, 2021

Price:       $4,950 / User License




1 INTRODUCTION 34
1.1 OBJECTIVES OF THE STUDY 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS AND EXCLUSIONS 34
1.3 MARKET SCOPE 35
1.3.1 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 36
1.5 STAKEHOLDERS 36
1.6 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DESIGN 38
2.1.1 RESEARCH DATA 38
FIGURE 1 RESEARCH DESIGN 38
2.1.2 SECONDARY SOURCES 39
2.1.2.1 Key data from secondary sources 39
2.1.3 PRIMARY SOURCES 40
FIGURE 2 PRIMARY SOURCES 40
2.1.3.1 Key data from primary sources 41
2.1.3.2 Key industry insights 42
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 43
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, TYPE, AND REGION 43
2.2 MARKET SIZE ESTIMATION 44
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 6 REVENUE SHARE ANALYSIS FOR IOT MEDICAL DEVICES MARKET 45
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
FIGURE 9 BOTTOM-UP APPROACH 46
FIGURE 10 TOP-DOWN APPROACH 47
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 48
FIGURE 11 DATA TRIANGULATION METHODOLOGY 48
2.4 LIMITATIONS 49
2.5 MARKET SHARE ANALYSIS 49
2.6 ASSUMPTIONS FOR THE STUDY 49
2.7 RISK ASSESSMENT/LIMITATIONS 49
2.8 COVID-19 HEALTH ASSESSMENT 50
2.9 COVID-19 ECONOMIC ASSESSMENT 50
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 50
3 EXECUTIVE SUMMARY 52
FIGURE 13 IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 52
FIGURE 14 VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 53
FIGURE 15 IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 53
FIGURE 16 IOT MEDICAL DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 54
FIGURE 17 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 54
FIGURE 18 IOT MEDICAL DEVICES MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 55
FIGURE 19 GEOGRAPHIC SNAPSHOT OF THE IOT MEDICAL DEVICES MARKET 55
4 PREMIUM INSIGHTS 57
4.1 IOT MEDICAL DEVICES MARKET OVERVIEW 57
FIGURE 20 COVID-19 OUTBREAK AND INCREASING GOVERNMENT INITIATIVES FOR PROMOTING DIGITAL HEALTH ARE DRIVING MARKET GROWTH 57
4.2 IOT MEDICAL DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 58
FIGURE 21 CHINA IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 58
4.3 REGIONAL MIX: IOT MEDICAL DEVICES MARKET (2019–2026) 59
FIGURE 22 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2021–2026) 59
4.4 IOT MEDICAL DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS,
2021 VS. 2026 (USD MILLION) 59
FIGURE 23 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE STUDY PERIOD 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
5.2.1 DRIVERS 60
TABLE 1 IMPACT ANALYSIS: DRIVERS 60
5.2.1.1 Government initiatives for promoting digital health 61
5.2.1.2 Growing need for cost-containment in healthcare delivery 62
FIGURE 24 HEALTHCARE SPENDING, BY COUNTRY, 2019 (% OF GDP) 62
5.2.1.3 Rising focus on active patient engagement and patient-centric care delivery 63
5.2.1.4 Evolution of high-speed networking technologies and increasing penetration of mobile platforms in healthcare 63
FIGURE 25 NUMBER OF SMARTPHONE USERS, BY COUNTRY, 2021 64
5.2.1.5 Growing focus on patient safety 64
5.2.2 RESTRAINTS 65
TABLE 2 IMPACT ANALYSIS: RESTRAINTS 65
5.2.2.1 High deployment cost of connected medical devices and the associated infrastructure 65
5.2.2.2 Insufficient IoT technology skills across healthcare organizations 66
5.2.3 OPPORTUNITIES 66
TABLE 3 IMPACT ANALYSIS: OPPORTUNITIES 66
5.2.3.1 Low doctor-to-patient ratio leading to increased dependency on self-operated eHealth platforms 66
5.2.4 CHALLENGES 67
TABLE 4 IMPACT ANALYSIS: CHALLENGES 67
5.2.4.1 Data security issues 67
5.2.4.2 Data management and interoperability concerns 67
5.3 PRICING ANALYSIS 68
TABLE 5 AVERAGE SYSTEM COST 68
5.4 PATENT ANALYSIS 69
5.4.1 PATENT PUBLICATION TRENDS 69
FIGURE 26 PATENT PUBLICATION TRENDS: 2011 TO 2021 69
5.4.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR IOT MEDICAL DEVICE PATENTS 69
TABLE 6 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR IOT MEDICAL DEVICES PATENTS 69
FIGURE 27 JURISDICTION ANALYSIS FOR TOP APPLICANTS 70
5.5 PORTER’S FIVE FORCES ANALYSIS 70
TABLE 7 IOT MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 70
5.5.1 THREAT FROM NEW ENTRANTS 71
5.5.2 THREAT FROM SUBSTITUTES 71
5.5.3 BARGAINING POWER OF SUPPLIERS 71
5.5.4 BARGAINING POWER OF BUYERS 71
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 72
5.6 VALUE CHAIN ANALYSIS 72
FIGURE 28 IOT MEDICAL DEVICES MARKET: VALUE CHAIN ANALYSIS 72
5.7 ECOSYSTEM MAP 73
FIGURE 29 IOT MEDICAL DEVICES MARKET: ECOSYSTEM MAPPING (2020) 73
FIGURE 30 IOT MEDICAL DEVICES MARKET: SUPPLY CHAIN (2020) 73
6 INDUSTRY INSIGHTS 74
6.1 INTRODUCTION 74
6.2 INDUSTRY TRENDS 74
6.2.1 INCREASING NUMBER OF PRODUCT LAUNCHES 74
TABLE 8 RECENTLY LAUNCHED IOT MEDICAL DEVICES 75
6.2.2 GROWING INTEGRATION OF CLOUD PLATFORMS AND SAAS IN THE HEALTHCARE ECOSYSTEM 75
6.2.3 INCREASING NUMBER OF COLLABORATIONS TO DRIVE INNOVATION 76
6.3 REGULATORY ANALYSIS 76
6.3.1 NORTH AMERICA 76
6.3.1.1 US 76
TABLE 9 TESTS AND CERTIFICATION REQUIREMENTS FOR WIRELESSLY CONNECTED MEDICAL DEVICES 77
TABLE 10 REGULATIONS & STANDARDS GOVERNING CONNECTED MEDICAL DEVICES 80
6.3.1.2 Canada 81
6.3.2 EUROPE 81
6.3.3 ASIA PACIFIC 82
6.3.3.1 Japan 82
6.3.3.2 China 83
6.3.3.3 India 83
6.4 TECHNOLOGY ANALYSIS 84
7 IOT MEDICAL DEVICES MARKET, BY PRODUCT 85
7.1 INTRODUCTION 86
TABLE 11 IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 86
7.2 VITAL SIGNS MONITORING DEVICES 87
TABLE 12 VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 87
TABLE 13 VITAL SIGNS MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 88
7.2.1 BLOOD GLUCOSE MONITORS 88
7.2.1.1 The shift toward CGM supports the demand for blood glucose monitoring 88
TABLE 14 BLOOD GLUCOSE MONITORS OFFERED BY KEY MARKET PLAYERS 89
TABLE 15 BLOOD GLUCOSE MONITORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 90
7.2.2 ECG/HEART RATE MONITORS 91
7.2.2.1 Rising CVD prevalence and focus on cost-containment drive market growth 91
TABLE 16 ECG/HEART RATE MONITORS OFFERED BY KEY MARKET PLAYERS 91
TABLE 17 ECG/HEART RATE MONITORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 93
7.2.3 BLOOD PRESSURE MONITORS 93
7.2.3.1 Growing prevalence of hypertension and obesity support market growth 93
TABLE 18 BLOOD PRESSURE MONITORS OFFERED BY KEY MARKET PLAYERS 94
TABLE 19 BLOOD PRESSURE MONITORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 95
7.2.4 MULTIPARAMETER MONITORS 96
7.2.4.1 Growing awareness and push toward home care contribute to market growth 96
TABLE 20 MULTIPARAMETER MONITORS OFFERED BY KEY MARKET PLAYERS 96
TABLE 21 MULTIPARAMETER MONITORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
7.2.5 OXIMETERS 97
7.2.5.1 Rising adoption is attributed to the availability of low-cost devices and focus on self-monitoring 97
TABLE 22 OXIMETERS OFFERED BY KEY MARKET PLAYERS 98
TABLE 23 OXIMETERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 99
7.3 IMAGING SYSTEMS 99
7.3.1 NEED TO COLLATE AND EFFICIENTLY TRANSMIT DATA FOR REMOTE VIEWING SUPPORTS MARKET GROWTH 99
TABLE 24 MAJOR IMAGING SYSTEMS AVAILABLE IN THE MARKET 100
TABLE 25 IMAGING SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 101
7.4 IMPLANTABLE CARDIAC DEVICES 101
TABLE 26 IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 102
TABLE 27 IMPLANTABLE CARDIAC DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 102
7.4.1 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS 103
7.4.1.1 ICDs dominate the implantable cardiac devices market 103
TABLE 28 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS OFFERED
BY KEY MARKET PLAYERS 103
TABLE 29 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
7.4.2 PACEMAKERS 105
7.4.2.1 Demand for pacemakers has dipped due to the use of ICDs 105
TABLE 30 PACEMAKERS OFFERED BY KEY MARKET PLAYERS 106
TABLE 31 PACEMAKERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 107
7.4.3 IMPLANTABLE CARDIAC MONITORS 107
7.4.3.1 Ease of remote monitoring has driven the use of implantable monitors 107
TABLE 32 IMPLANTABLE CARDIAC MONITORS OFFERED BY KEY MARKET PLAYERS 108
TABLE 33 IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
7.5 PATIENT MONITORS 109
7.5.1 LONG DEVICE LIFECYCLES AFFECT OVERALL SALES IN THE MARKET 109
TABLE 34 PATIENT MONITORS OFFERED BY KEY MARKET PLAYERS 109
TABLE 35 PATIENT MONITORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 111
7.6 RESPIRATORY DEVICES 111
7.6.1 THE RISING PREVALENCE OF ASTHMA AND RESPIRATORY DISORDERS DRIVES DEMAND FOR RESPIRATORY DEVICES 111
TABLE 36 RESPIRATORY DEVICES OFFERED BY KEY MARKET PLAYERS 112
TABLE 37 RESPIRATORY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 113
7.7 INFUSION PUMPS 113
7.7.1 THE RISK OF SECURITY BREACHES MAY AFFECT MARKET GROWTH TO A CERTAIN EXTENT 113
TABLE 38 INFUSION PUMPS OFFERED BY KEY MARKET PLAYERS 113
TABLE 39 INFUSION PUMPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 114
7.8 FETAL MONITORING DEVICES 114
7.8.1 GROWING INCIDENCE OF NEWBORN DEATHS, MATERNAL DEATH, AND STILLBIRTHS IS A KEY DRIVER OF MARKET GROWTH 114
TABLE 40 FETAL MONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 115
TABLE 41 FETAL MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 116
7.9 NEUROLOGICAL DEVICES 116
7.9.1 PRODUCT DEVELOPMENT AND TECHNOLOGICAL ADVANCEMENTS HAVE MADE INNOVATIONS AVAILABLE IN THE MARKET 116
TABLE 42 NEUROLOGICAL DEVICES OFFERED BY KEY MARKET PLAYERS 117
TABLE 43 NEUROLOGICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 118
7.10 VENTILATORS 118
7.10.1 HIGH DEMAND FOR INTENSIVE CARE ENSURES MARKET GROWTH 118
TABLE 44 VENTILATORS OFFERED BY KEY MARKET PLAYERS 118
TABLE 45 VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 119
7.11 ANESTHESIA MACHINES 120
7.11.1 NORTH AMERICAN COUNTRIES FORM THE LARGEST MARKETS FOR ANESTHESIA MACHINES 120
TABLE 46 ANESTHESIA MACHINES OFFERED BY KEY MARKET PLAYERS 120
TABLE 47 ANESTHESIA MACHINES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
7.12 HEARING DEVICES 121
7.12.1 THE GROWING PREVALENCE OF HEARING ISSUES AND RISING ADOPTION OF ADVANCED AIDS ARE KEY DRIVERS FOR THIS MARKET 121
TABLE 48 HEARING DEVICES OFFERED BY KEY MARKET PLAYERS 122
TABLE 49 HEARING DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
7.13 OTHER DEVICES 123
TABLE 50 OTHER IOT MEDICAL PRODUCTS OFFERED BY KEY MARKET PLAYERS 123
TABLE 51 OTHER IOT MEDICAL PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 125
8 IOT MEDICAL DEVICES MARKET, BY TYPE 126
8.1 INTRODUCTION 127
TABLE 52 IOT MEDICAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 127
8.2 STATIONARY MEDICAL DEVICES 127
8.2.1 STATIONARY MEDICAL DEVICES DOMINATE THE IOT MEDICAL DEVICES MARKET 127
TABLE 53 MAJOR STATIONARY IOT MEDICAL DEVICES AVAILABLE IN THE MARKET 128
TABLE 54 STATIONARY IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
8.3 IMPLANTABLE MEDICAL DEVICES 130
8.3.1 RISING INCIDENCE OF CVD AND NEUROLOGICAL DISEASES HAVE DRIVEN DEMAND FOR IMPLANTABLES 130
TABLE 55 MAJOR IMPLANTABLE IOT MEDICAL DEVICES AVAILABLE IN THE MARKET 130
TABLE 56 IMPLANTABLE IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 131
8.4 WEARABLE MEDICAL DEVICES 132
8.4.1 WEARABLES TO SEE HIGH GROWTH IN THE IOT MEDICAL DEVICES MARKET 132
TABLE 57 MAJOR WEARABLE IOT MEDICAL DEVICES AVAILABLE IN THE MARKET 132
TABLE 58 WEARABLE IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 133
8.5 OTHER IOT MEDICAL DEVICES 134
TABLE 59 OTHER IOT MEDICAL DEVICES AVAILABLE IN THE MARKET 134
TABLE 60 OTHER IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 135
9 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY 136
9.1 INTRODUCTION 137
TABLE 61 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2019–2026 (USD MILLION) 137
9.2 WI-FI 137
9.2.1 WI-FI DOMINATES THE OVERALL MARKET BY CONNECTIVITY TECHNOLOGY 137
TABLE 62 WI-FI-ENABLED IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 138
9.3 BLUETOOTH 138
9.3.1 BLUETOOTH-ENABLED IOT DEVICES TO SEE HIGHEST GROWTH 138
TABLE 63 BLUETOOTH-ENABLED IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 139
9.4 ZIGBEE 140
9.4.1 ADVANTAGES OF THE TECHNOLOGY AND SUPPORT FOR A VARIETY OF DEVICES PROMOTES THE MARKET GROWTH 140
TABLE 64 ZIGBEE-ENABLED IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 140
9.5 OTHER CONNECTIVITY TECHNOLOGIES 141
TABLE 65 OTHER IOT MEDICAL DEVICE CONNECTIVITY TECHNOLOGIES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 141
10 IOT MEDICAL DEVICES MARKET, BY END USER 142
10.1 INTRODUCTION 143
TABLE 66 IOT MEDICAL DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 143
10.2 HOSPITALS & CLINICS 143
10.2.1 HOSPITALS & CLINICS DOMINATE THE IOT MEDICAL DEVICES END-USER MARKET 143
TABLE 67 IOT MEDICAL DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 144
10.3 NURSING HOMES, ASSISTED LIVING FACILITIES, LONG-TERM CARE CENTERS, AND HOME CARE SETTINGS 145
10.3.1 THE GROWING GERIATRIC POPULATION AND RISING INCIDENCE OF CHRONIC DISORDERS CONTRIBUTE TO SEGMENT GROWTH 145
TABLE 68 IOT MEDICAL DEVICES MARKET FOR NURSING HOMES, ASSISTED LIVING FACILITIES, LONG-TERM CARE CENTERS, AND HOME CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 146
10.4 OTHER END USERS 146
TABLE 69 IOT MEDICAL DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 147
11 IOT MEDICAL DEVICES MARKET, BY REGION 148
11.1 INTRODUCTION 149
TABLE 70 IOT MEDICAL DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 149
11.2 NORTH AMERICA 150
FIGURE 31 NORTH AMERICA: IOT MEDICAL DEVICES MARKET SNAPSHOT 151
TABLE 71 NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 152
TABLE 72 NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 152
TABLE 73 NORTH AMERICA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 74 NORTH AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 75 NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY TYPE,
019–2026 (USD MILLION) 153
TABLE 76 NORTH AMERICA: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 154
TABLE 77 NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 154
11.2.1 US 154
11.2.1.1 The US dominates the North American IoT medical devices market 154
TABLE 78 US: MACROECONOMIC INDICATORS 155
TABLE 79 US: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 80 US: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 81 US: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 82 US: IOT MEDICAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 83 US: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2019–2026 (USD MILLION) 157
TABLE 84 US: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 158
11.2.2 CANADA 158
11.2.2.1 Canada to grow at a slower rate than the US 158
TABLE 85 CANADA: MACROECONOMIC INDICATORS 159
TABLE 86 CANADA: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 159
TABLE 87 CANADA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 88 CANADA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 89 CANADA: IOT MEDICAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 90 CANADA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 161
TABLE 91 CANADA: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 161
11.3 EUROPE 161
TABLE 92 EUROPE: IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 162
TABLE 93 EUROPE: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 163
TABLE 94 EUROPE: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 95 EUROPE: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 96 EUROPE: IOT MEDICAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 97 EUROPE: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 164
TABLE 98 EUROPE: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 165
11.3.1 GERMANY 165
11.3.1.1 Germany holds the largest share of the European market 165
TABLE 99 GERMANY: MACROECONOMIC INDICATORS 166
TABLE 100 GERMANY: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 166
TABLE 101 GERMANY: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 102 GERMANY: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 103 GERMANY: IOT MEDICAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 104 GERMANY: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 168
TABLE 105 GERMANY: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 168
11.3.2 UK 168
11.3.2.1 Wearables have seen high penetration in the UK market 168
TABLE 106 UK: MACROECONOMIC INDICATORS 169
TABLE 107 UK: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 170
TABLE 108 UK: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 109 UK: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 110 UK: IOT MEDICAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 111 UK: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2019–2026 (USD MILLION) 171
TABLE 112 UK: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 172
11.3.3 FRANCE 172
11.3.3.1 Government support for eHealth and favorable regulatory scenario to drive the market 172
TABLE 113 FRANCE: MACROECONOMIC INDICATORS 173
TABLE 114 FRANCE: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 173
TABLE 115 FRANCE: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 116 FRANCE: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 117 FRANCE: IOT MEDICAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 118 FRANCE: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 175
TABLE 119 FRANCE: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 175
11.3.4 ITALY 175
11.3.4.1 Integration in healthcare is ongoing but varies across regions in Italy 175
TABLE 120 ITALY: MACROECONOMIC INDICATORS 176
TABLE 121 ITALY: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 176
TABLE 122 ITALY: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 123 ITALY: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 124 ITALY: IOT MEDICAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 177
TABLE 125 ITALY: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 178
TABLE 126 ITALY: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 178
11.3.5 SPAIN 178
11.3.5.1 High smartphone penetration and Internet access indicate opportunities for market players 178
TABLE 127 SPAIN: MACROECONOMIC INDICATORS 179
TABLE 128 SPAIN: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 179
TABLE 129 SPAIN: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 130 SPAIN: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 131 SPAIN: IOT MEDICAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 132 SPAIN: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 181
TABLE 133 SPAIN: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 181
11.3.6 REST OF EUROPE 181
TABLE 134 ROE: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 182
TABLE 135 ROE: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 182
TABLE 136 ROE: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 183
TABLE 137 ROE: IOT MEDICAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 138 ROE: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 183
TABLE 139 ROE: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 184
11.4 ASIA PACIFIC 184
FIGURE 32 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET SNAPSHOT 185
TABLE 140 APAC: IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 186
TABLE 141 APAC: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 186
TABLE 142 APAC: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 143 APAC: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 144 APAC: IOT MEDICAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 145 APAC: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 188
TABLE 146 APAC: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 188
11.4.1 CHINA 188
11.4.1.1 High smartphone ownership and government emphasis on healthcare reform to drive market growth 188
TABLE 147 CHINA: MACROECONOMIC INDICATORS 189
TABLE 148 CHINA: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 190
TABLE 149 CHINA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 150 CHINA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 151 CHINA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 152 CHINA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 191
TABLE 153 CHINA: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 192
11.4.2 JAPAN 192
11.4.2.1 Japan has one of the largest elderly populations in the world 192
TABLE 154 JAPAN: MACROECONOMIC INDICATORS 193
TABLE 155 JAPAN: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 193
TABLE 156 JAPAN: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 157 JAPAN: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 158 JAPAN: IOT MEDICAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 159 JAPAN: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 195
TABLE 160 JAPAN: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 195
11.4.3 INDIA 195
11.4.3.1 Strain on healthcare resources and need to expand access to favor telemedicine & IoT device adoption in India 195
TABLE 161 INDIA: MACROECONOMIC INDICATORS 196
TABLE 162 INDIA: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 197
TABLE 163 INDIA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 164 INDIA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 165 INDIA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 166 INDIA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 198
TABLE 167 INDIA: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 199
11.4.4 REST OF ASIA PACIFIC 199
TABLE 168 ROAPAC: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 200
TABLE 169 ROAPAC: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 170 ROAPAC: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 171 ROAPAC: IOT MEDICAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 172 ROAPAC: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 201
TABLE 173 ROAPAC: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 202
11.5 LATIN AMERICA 202
TABLE 174 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 202
TABLE 175 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 203
TABLE 176 LATIN AMERICA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 203
TABLE 177 LATIN AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 178 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 179 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 204
TABLE 180 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 205
11.5.1 BRAZIL 205
11.5.1.1 Brazil dominates the LATAM market for IoT medical devices 205
TABLE 181 BRAZIL: MACROECONOMIC INDICATORS 205
TABLE 182 BRAZIL: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
019–2026 (USD MILLION) 206
TABLE 183 BRAZIL: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 206
TABLE 184 BRAZIL: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 207
TABLE 185 BRAZIL: IOT MEDICAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 207
TABLE 186 BRAZIL: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 207
TABLE 187 BRAZIL: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 208
11.5.2 MEXICO 208
11.5.2.1 Rising collaborations and focus on digitization to support the IoT medical devices market in Mexico 208
TABLE 188 MEXICO: MACROECONOMIC INDICATORS 208
TABLE 189 MEXICO: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 209
TABLE 190 MEXICO: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 191 MEXICO: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 192 MEXICO: IOT MEDICAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 193 MEXICO: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 210
TABLE 194 MEXICO: IOT MEDICAL DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 211
11.5.3 REST OF LATIN AMERICA 211
TABLE 195 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 212
TABLE 196 REST OF LATIN AMERICA: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 197 REST OF LATIN AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 198 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 213
TABLE 199 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 213
TABLE 200 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 214
11.6 MIDDLE EAST AND AFRICA 214
11.6.1 MEA ACCOUNTS FOR THE SMALLEST SHARE OF THE MARKET BUT IS EXPECTED TO SEE SIGNIFICANT GROWTH 214
TABLE 201 MIDDLE EAST AND AFRICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 215
TABLE 202 MIDDLE EAST AND AFRICA: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 203 MIDDLE EAST AND AFRICA: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 204 MIDDLE EAST AND AFRICA: IOT MEDICAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 216
TABLE 205 MIDDLE EAST AND AFRICA: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2019–2026 (USD MILLION) 216
TABLE 206 MIDDLE EAST AND AFRICA: IOT MEDICAL DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 217
12 COMPETITIVE LANDSCAPE 218
12.1 INTRODUCTION 218
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 218
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE IOT MEDICAL DEVICES MARKET 219
12.3 MARKET SHARE ANALYSIS 220
FIGURE 33 IOT MEDICAL DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 220
12.4 REVENUE SHARE ANALYSIS OF THE TOP FIVE MARKET PLAYERS 221
FIGURE 34 IOT MEDICAL DEVICES MARKET: REVENUE SHARE ANALYSIS OF
THE KEY MARKET PLAYERS 221
12.5 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE IOT MEDICAL DEVICES MARKET 222
TABLE 207 COMPANY FOOTPRINT 222
FIGURE 35 COMPANY PRODUCT TYPE FOOTPRINT 223
TABLE 208 COMPANY REGION FOOTPRINT 224
TABLE 209 COMPANY TYPE FOOTPRINT 225
12.6 IOT MEDICAL DEVICES MARKET: R&D EXPENDITURE 226
FIGURE 36 R&D EXPENDITURE OF THE KEY PLAYERS IN THE IOT MEDICAL DEVICES MARKET 226
12.7 COMPANY EVALUATION QUADRANT 227
12.7.1 STARS 227
12.7.2 EMERGING LEADERS 227
12.7.3 PERVASIVE PLAYERS 227
12.7.4 PARTICIPANTS 227
FIGURE 37 IOT MEDICAL DEVICES MARKET: COMPANY EVALUATION QUADRANT, 2020 228
12.8 COMPANY EVALUATION QUADRANT: STARTUPS/SMES 229
12.8.1 PROGRESSIVE COMPANIES 229
12.8.2 STARTING BLOCKS 229
12.8.3 RESPONSIVE COMPANIES 229
12.8.4 DYNAMIC COMPANIES 229
FIGURE 38 IOT MEDICAL DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2020 230
12.9 COMPETITIVE SCENARIO 231
12.9.1 KEY COLLABORATIONS & PARTNERSHIPS 231
TABLE 210 COLLABORATIONS AND PARTNERSHIPS (2020–2021) 231
12.9.2 KEY PRODUCT LAUNCHES 231
TABLE 211 PRODUCT LAUNCHES (2020–2021) 231
12.9.3 KEY ACQUISITIONS 232
TABLE 212 ACQUISITIONS (2020–2021) 232
12.9.4 KEY AGREEMENTS 232
TABLE 213 AGREEMENTS (2018–2020) 232
13 COMPANY PROFILES 233
13.1 KEY COMPANIES 233
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1 MEDTRONIC 233
TABLE 214 MEDTRONIC: BUSINESS OVERVIEW 233
FIGURE 39 MEDTRONIC: COMPANY SNAPSHOT (2020) 234
13.1.2 GE HEALTHCARE 241
TABLE 215 GE HEALTHCARE: BUSINESS OVERVIEW 241
FIGURE 40 GE HEALTHCARE: COMPANY SNAPSHOT (2020) 242
13.1.3 PHILIPS HEALTHCARE (PHILIPS) 246
TABLE 216 PHILIPS HEALTHCARE: BUSINESS OVERVIEW 246
FIGURE 41 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 247
13.1.4 ABBOTT LABORATORIES 253
TABLE 217 ABBOTT LABORATORIES: BUSINESS OVERVIEW 253
FIGURE 42 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020) 254
13.1.5 BOSTON SCIENTIFIC 257
TABLE 218 BOSTON SCIENTIFIC: BUSINESS OVERVIEW 257
FIGURE 43 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2020) 258
13.1.6 OMRON CORPORATION 262
TABLE 219 OMRON CORPORATION: BUSINESS OVERVIEW 262
FIGURE 44 OMRON CORPORATION: COMPANY SNAPSHOT (2020) 263
13.1.7 HILL-ROM HOLDINGS, INC. 266
TABLE 220 HILL-ROM HOLDINGS, INC.: BUSINESS OVERVIEW 266
FIGURE 45 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2020) 267
13.1.8 BIOTRONIK 270
TABLE 221 BIOTRONIK: BUSINESS OVERVIEW 270
13.1.9 JOHNSON & JOHNSON 272
TABLE 222 JOHNSON & JOHNSON: BUSINESS OVERVIEW 272
FIGURE 46 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020) 273
13.1.10 NIHON KOHDEN CORPORATION 275
TABLE 223 NIHON KOHDEN: BUSINESS OVERVIEW 275
13.1.11 STANLEY HEALTHCARE 277
TABLE 224 STANLEY HEALTHCARE: BUSINESS OVERVIEW 277
FIGURE 47 STANLEY BLACK & DECKER: COMPANY SNAPSHOT (2020) 278
13.1.12 SIEMENS 280
TABLE 225 SIEMENS: BUSINESS OVERVIEW 280
FIGURE 48 SIEMENS AG: COMPANY SNAPSHOT (2020) 281
13.1.13 HONEYWELL INTERNATIONAL 283
TABLE 226 HONEYWELL INTERNATIONAL INC.: BUSINESS OVERVIEW 283
FIGURE 49 HONEYWELL INTERNATIONAL: COMPANY SNAPSHOT (2020) 284
13.1.14 ALIVECOR 285
TABLE 227 ALIVECOR: BUSINESS OVERVIEW 285
13.1.15 DRÄGERWERK AG & CO 287
TABLE 228 DRÄGERWERK AG & CO: BUSINESS OVERVIEW 287
FIGURE 50 DRÄGERWERK AG & CO: COMPANY SNAPSHOT (2020) 288
13.2 OTHER PLAYERS 290
13.2.1 NONIN 290
TABLE 229 NONIN MEDICAL: BUSINESS OVERVIEW 290
13.2.2 AMD GLOBAL TELEMEDICINE 292
TABLE 230 AMD GLOBAL TELEMEDICINE: BUSINESS OVERVIEW 292
13.2.3 IHEALTH LABS 293
TABLE 231 IHEALTH LABS: BUSINESS OVERVIEW 293
13.2.4 AEROTEL MEDICAL SYSTEMS 294
13.2.5 AGAMATRIX 295
13.2.6 HUNTLEIGH 296
13.2.7 RESMED 297
13.2.8 MASIMO CORPORATION 298
13.2.9 INFINIUM MEDICAL 299
13.2.10 SMITHS MEDICAL 299
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
14 APPENDIX 300
14.1 INSIGHTS OF INDUSTRY EXPERTS 300
14.2 DISCUSSION GUIDE 301
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 305
14.4 AVAILABLE CUSTOMIZATIONS 307
14.5 RELATED REPORTS 308
14.6 AUTHOR DETAILS 309

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127